Home News Covid-19

Wealthy nations will have 1.2 billion doses they don’t need

Bloomberg
Bloomberg9/5/2021 09:10 PM GMT+08  • 4 min read
Wealthy nations will have 1.2 billion doses they don’t need
A more coordinated effort is needed to allow countries with ample supplies to resell and donate doses
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Wealthy countries face mounting pressure to divert Covid vaccine supplies to lower-income regions, with a new analysis showing they’ll likely have about 1.2 billion extra doses available by the end of the year.

The US, Britain, European nations and others could satisfy their own needs -- vaccinating about 80% of their populations over the age of 12 and moving ahead with booster programs -- and still have large quantities to redistribute globally, according to London-based analytics firm Airfinity Ltd.

Those governments have so far delivered a meagre amount of the supplies they’ve pledged to poorer countries as some move forward with plans for booster shots in a race to combat the delta variant. Health advocates worry that the slow pace will prolong the pandemic and increase the risk more worrisome variants will emerge. Some are also calling for more transparency on the agreements between governments and manufacturers.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now